Non-Muscle Invasive Bladder Cancer Information and Resources

Fund Status and Eligibility

Fully Allocated - Effective 06/06/2014, we are unable to process applications that are pending or accept new or renewal applications at this time. Should additional funding for Non-Muscle Invasive Bladder Cancer Fund applicants become available in the future, it will be necessary to re-apply if assistance is still needed.

Maximum Award Level: $3,500 Per Year

Eligibility Criteria

  • Patient should be insured and insurance must cover the medication for which patient seeks assistance.
  • Patient must have a confirmed diagnosis of Non-Muscle Invasive Bladder Cancer.
  • Patient must reside and receive treatment in the United States.
  • Patient's income must fall below 400% of the Federal Poverty Guideline (FPG) with consideration of the Cost of Living Index (COLI) and the number in the household.

Get Help With Your Treatment: How to Apply Online

Information About the Disease

Bladder cancer is the fourth most common cancer among men and the ninth most common among women in the United States. It most often occurs in older people: nearly 90% of patients are over age 55.

Cancer that begins and stays in the cells lining the bladder without growing into the deeper, main muscle layer of the bladder is referred to as noninvasive or non-muscle invasive bladder cancer. The majority of people (approximately 75%) diagnosed with bladder cancer are diagnosed with non-muscle invasive bladder cancer. The National Cancer Institute defines recurrent bladder cancer as cancer that has recurred or come back after it has been treated, usually after a period of time during which the cancer could not be detected. Although treatment is aimed at getting rid of all cancer cells, a few cancerous cells may survive. These undetected cancer cells multiply, becoming recurrent bladder cancer. Even in survivors who are treated according to practice guidelines, bladder cancer often recurs. Non-muscle invasive bladder cancer has a 50 to 90% probability of recurrence. Recurrence can be local, meaning the tumor recurs in or near the original tumor or cancer site. Recurrent bladder cancer can also be distant, where the cancer has spread to adjacent organs or even distant organs in the body. Non-muscle invasive bladder cancers commonly recur locally in the bladder.

Non-Muscle Invasive Bladder Cancer Resources

American Urological Association

Phone: 800-828-7866 -

Bladder Cancer Advocacy Network

Phone: 888-901-BCAN -


The Patient Advocate Foundation's (PAF) Co-Pay Relief (CPR) Program does not review the information contained on the website links provided for content, accuracy or completeness. Use of and access to this information is subject to the terms, limitations and conditions as outlined on the accessed websites.

PAF Co-Pay Relief Program makes no representation as to the accuracy or any other aspect of the information contained on any website accessed from the CPR website, nor does PAF Co-Pay Relief Program necessarily endorse the website information provided.

The information presented on the PAF Co-Pay Relief website is provided for general information only and is not intended as a substitute for medical care. Please talk with your healthcare provider about any information you acquire from this or any other website accessed through the PAF Co-Pay Relief program website.